Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated with oral antidiabetic drugs such as sulfonylureas, biguanides, and thiazolidinediones. Rosiglitazone treatment has been shown to increase adipogenesis in bone marrow and to induce bone loss. In this...
Guardado en:
| Autores principales: | Molinuevo, María Silvina, Schurman, León, McCarthy, Antonio Desmond, Cortizo, Ana María, Tolosa, María José Anahí, Gangoiti, María Virginia, Arnol, Verónica, Sedlinsky, Claudia |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/82465 |
| Aporte de: |
Ejemplares similares
-
Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin
por: Tolosa, María José Anahí, et al.
Publicado: (2013) -
Bone marrow transplantation
Publicado: (1986) -
Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
por: Sbaraglini, María Laura, et al.
Publicado: (2014) -
Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy?
por: McCarthy, Antonio Desmond, et al.
Publicado: (2016) -
Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment
por: Felice, Juan Ignacio, et al.
Publicado: (2017)